BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 28247107)

  • 1. Effect of collagen vascular disease-associated interstitial lung disease on the outcomes of lung cancer surgery.
    Maeda H; Kanzaki M; Sakamoto K; Isaka T; Oyama K; Murasugi M; Onuki T
    Surg Today; 2017 Sep; 47(9):1072-1079. PubMed ID: 28247107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ablation of Stage I-II Non-Small Cell Lung Cancer in Patients With Interstitial Lung Disease: A Multicenter Retrospective Study.
    Fintelmann FJ; Graur A; Oueidat K; Simon J; Barnes JMH; McDermott S; Genshaft SJ; Healey TT; Suh RD; Maxwell AWP; Abtin F
    AJR Am J Roentgenol; 2024 Feb; 222(2):e2330300. PubMed ID: 37966037
    [No Abstract]   [Full Text] [Related]  

  • 3. Risk factors for acute exacerbation in lung cancer complicated by interstitial lung disease with slight reticular shadows.
    Takahara Y; Tanaka T; Ishige Y; Shionoya I; Yamamura K; Sakuma T; Nishiki K; Nakase K; Nojiri M; Kato R; Shinomiya S; Fujimoto Y; Oikawa T; Mizuno S
    Thorac Cancer; 2021 Oct; 12(20):2758-2766. PubMed ID: 34409749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of nintedanib-induced gastrointestinal adverse events between patients with systemic sclerosis-associated interstitial lung disease and idiopathic interstitial pneumonias.
    Imai M; Okabayashi H; Akaike K; Hamada S; Masunaga A; Ichiyasu H; Sakagami T
    Respir Investig; 2024 May; 62(3):317-321. PubMed ID: 38395006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Automated CT quantification of interstitial lung abnormality and interstitial lung disease according to the Fleischner Society in patients with resectable lung cancer: prognostic significance.
    Ahn Y; Lee SM; Choi S; Lee JS; Choe J; Do KH; Seo JB
    Eur Radiol; 2023 Nov; 33(11):8251-8262. PubMed ID: 37266656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of local ablative therapy for patients with NSCLC and coexisting interstitial lung disease.
    Shao C; Zhi X; Mao S; Wu L; Yu J; Yang S; Wang W; Jia K; Luo L; Liu X; Jiang T; Zhou F; Chen B; Wang L; Gao G; Shi J; Chen X; Wu F; Ren S
    Thorac Cancer; 2024 Apr; 15(10):778-787. PubMed ID: 38400790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High preoperative C-reactive protein level is a risk factor for acute exacerbation of interstitial lung disease after non-pulmonary surgery.
    Takao S; Masuda T; Yamaguchi K; Sakamoto S; Horimasu Y; Nakashima T; Miyamoto S; Iwamoto H; Fujitaka K; Hamada H; Hattori N
    Medicine (Baltimore); 2019 Feb; 98(5):e14296. PubMed ID: 30702600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal deposition of collagen/elastic vascular fibres and prognostic significance in idiopathic interstitial pneumonias.
    Parra ER; Kairalla RA; de Carvalho CR; Capelozzi VL
    Thorax; 2007 May; 62(5):428-37. PubMed ID: 17251318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between Interstitial Lung Disease and Outcomes After Lung Cancer Resection.
    Axtell AL; David EA; Block MI; Parsons N; Habib R; Muniappan A
    Ann Thorac Surg; 2023 Sep; 116(3):533-541. PubMed ID: 37271447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of interstitial lung disease and simultaneous lung cancer on therapeutic possibilities and survival.
    Barczi E; Nagy T; Starobinski L; Kolonics-Farkas A; Eszes N; Bohacs A; Tarnoki AD; Tarnoki DL; Müller V
    Thorac Cancer; 2020 Jul; 11(7):1911-1917. PubMed ID: 32401433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical outcomes and perioperative risk factors of patients with interstitial lung disease after pulmonary resection.
    Huang C; Sun YG; Ma C; Jiao P; Wu QJ; Tian WX; Yu HB; Tong HF
    J Cardiothorac Surg; 2024 Feb; 19(1):72. PubMed ID: 38331909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. <Editors' Choice> Comparison of clinical features between patients with acute exacerbation of idiopathic interstitial pneumonia and collagen vascular disease-associated interstitial pneumonia.
    Kata Y; Hara Y; Murohashi K; Saigusa Y; Nagasawa R; Tagami Y; Fujii H; Aoki A; Nishikawa Y; Tanaka K; Watanabe K; Horita N; Kobayashi N; Yamamoto M; Kudo M; Kaneko T
    Nagoya J Med Sci; 2023 Aug; 85(3):602-611. PubMed ID: 37829474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute exacerbation predicting poor outcomes in idiopathic interstitial pneumonia and advanced lung cancer patients undergoing cytotoxic chemotherapy.
    Miyamoto A; Michimae H; Nakahara Y; Akagawa S; Nakagawa K; Minegishi Y; Ogura T; Hontsu S; Date H; Takahashi K; Homma S; Kishi K;
    Sci Rep; 2024 May; 14(1):10162. PubMed ID: 38702426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of tumour mutation burden in patients with non-small cell lung cancer and interstitial lung disease.
    Kobayashi H; Serizawa M; Naito T; Konno H; Kojima H; Mizuno T; Isaka M; Endo M; Nagashima T; Kusuhara M; Urakami K; Ohshima K; Yamaguchi K; Ohde Y; Takahashi T
    Respirology; 2020 Aug; 25(8):850-854. PubMed ID: 31694070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical impact of pre-existing acute exacerbation in patients with interstitial lung disease who underwent lung transplantation.
    Kim HH; Kim HC; Shim TS; Ahn JH; Huh JW; Hong SB; Lee GD; Kim DK; Park SI; Choi S
    Respir Res; 2023 Dec; 24(1):307. PubMed ID: 38062465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Interstitial Lung Diseases with Deep Learning Method of Two Major Computed Tomography Patterns.
    Kiziloğlu HA; Çevik E; Zengin K
    Curr Med Imaging; 2024; 20():e15734056279295. PubMed ID: 38415479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical spectrum of Chinese hospitalized lung cancer patients with concomitant interstitial lung disease: before and after the new era of LC treatment.
    Chen R; Shao C; Liu X; Huang H; Pan B; Xu K; Zhu R; Li M; Zhao Y; Chen K; Wang M; Xu Z
    Clin Exp Med; 2023 Oct; 23(6):2321-2330. PubMed ID: 36715832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and Treatment of Lung Cancer in the Setting of Interstitial Lung Disease.
    Fisher DA; Murphy MC; Montesi SB; Hariri LP; Hallowell RW; Keane FK; Lanuti M; Mooradian MJ; Fintelmann FJ
    Radiol Clin North Am; 2022 Nov; 60(6):993-1002. PubMed ID: 36202484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics and prognostic impact of acute exacerbations in patients with interstitial lung disease and lung cancer: A single-center, retrospective cohort study.
    Hyun DG; Han SJ; Ji W; Choi CM; Lee JC; Kim HC
    Thorac Cancer; 2023 Nov; 14(33):3323-3330. PubMed ID: 37772425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The epidemiology of interstitial lung disease and its association with lung cancer.
    Raghu G; Nyberg F; Morgan G
    Br J Cancer; 2004 Aug; 91 Suppl 2(Suppl 2):S3-10. PubMed ID: 15340372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.